Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif®) in Two Phase III Studies in Multiple Sclerosis
MS Patient, Ph.D.: Can We Separate Anxiety and Gender in MS?
A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).
Autoimmunity's next top models.
CMSC ACTRIMS Cooperative Annual Meeting
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.
MS Research Roundup: November 21, 2014
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
Episode 50 with Dr. David Tabby on balance vests for MS
CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS): A 3-Year Interim Report.
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
Low testosterone is associated with disability in men with multiple sclerosis.
Combination of IFN beta-1a (Avonex) and mycophenolate mofetil (Cellcept) in multiple sclerosis.
ISN-APSN Biennial Meeting
Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.
The origin and application of experimental autoimmune encephalomyelitis.
Defining the clinical course of multiple sclerosis: The 2013 revisions.
Nature Medicine Retracts MS Paper With Ghost Data by Former GSK Researcher
ACTRIMS-ECTRIMS 2014 -- Day 4
Episode 47 with Dr. Hans Lassmann on oxidative stress in MS

Pages